MEDS VS JNJ Stock Comparison
Performance
MEDS10/100
10/100
MEDS returned -41.09% in the last 12 months. Based on SPY's performance of -13.95%, its performance is below average giving it a score of 10 of 100.
JNJ73/100
73/100
JNJ returned -15.84% in the last 12 months. Based on SPY's performance of -20.60%, its performance is above average giving it a score of 73 of 100.
Technicals
MEDS36/100
36/100
MEDS receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
JNJ14/100
14/100
JNJ receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
MEDS10/100
10/100
MEDS has missed earnings 9 times in the last 20 quarters.
JNJ100/100
100/100
JNJ has missed earnings 0 times in the last 20 quarters.
Profit
MEDS22/100
22/100
Out of the last 20 quarters, MEDS has had 6 profitable quarters and has increased their profits year over year on 2 of them.
JNJ74/100
74/100
Out of the last 20 quarters, JNJ has had 19 profitable quarters and has increased their profits year over year on 9 of them.
Volatility
MEDS52/100
52/100
MEDS has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.
JNJ43/100
43/100
JNJ has had a lower than average amount of volatility over the last 12 months giving it a score of 43 of 100.
Analyst Price Targets
MEDS
"Analyst Price Targets" not found for MEDS
JNJ63/100
63/100
23 analysts offer 12-month price targets for JNJ. Together, they have an average target of 176.5, the most optimistic target put JNJ at 205 within 12-months and the most pessimistic has JNJ at 90.
Sentiment
MEDS
"Sentiment" not found for MEDS
JNJ72/100
72/100
JNJ had a bullish sentiment score of 71.87% across Twitter and StockTwits over the last 12 months. It had an average of 205.31 posts, 3,341.61 comments, and 16,552.61 likes per day.
Dividend
MEDS
"Dividend" not found for MEDS
JNJ100/100
100/100
JNJ's most recent dividend was $0.90 per share, based on a share price of $145.60. It was a payout ratio of 61.39% compared to their total earnings.
All score calculations are broken down here to help you make more informed investing decisions
TRxADE HEALTH, Inc. Common Stock Summary
Nasdaq / MEDS
Healthcare
Medical - Pharmaceuticals
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Johnson & Johnson Summary
New York Stock Exchange / JNJ
Healthcare
Drug Manufacturers - General
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare MEDS to other companies in the same or a similar industry.